Universidad de Puerto Rico - Recinto de Ciencias Médicas – Trademark Portfolio
Entity Type: 03
Universidad de Puerto Rico - Recinto de Ciencias Médicas holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ASMARLÍN. The owner is based in San Juan, PR.
Jardín Botánico Sur 1187 Calle Flamboyán
San Juan, PR 00926-1117
Showing of trademarks Trademarks
Trademark Classifications
Universidad de Puerto Rico - Recinto de Ciencias Médicas's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Universidad de Puerto Rico - Recinto de Ciencias Médicas have?
Universidad de Puerto Rico - Recinto de Ciencias Médicas has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Universidad de Puerto Rico - Recinto de Ciencias Médicas file in?
Universidad de Puerto Rico - Recinto de Ciencias Médicas files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Universidad de Puerto Rico - Recinto de Ciencias Médicas's most well-known trademarks?
Universidad de Puerto Rico - Recinto de Ciencias Médicas's registered trademark portfolio includes well-known marks such as ASMARLÍN. These are among 1 currently registered trademark in the portfolio.
What is Universidad de Puerto Rico - Recinto de Ciencias Médicas's trademark registration success rate?
Universidad de Puerto Rico - Recinto de Ciencias Médicas has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.